IVRATICAV

Serial Number 98230479
730

Registration Progress

Application Filed
Oct 19, 2023
Under Examination
Sep 3, 2024
Approved for Publication
Jul 9, 2024
Published for Opposition
Jul 9, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Sep 03, 2025 35 days

Trademark Image

IVRATICAV

Basic Information

Serial Number
98230479
Filing Date
October 19, 2023
Published for Opposition
July 9, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Feb 14, 2025
Application
Pending
Classes
005

Rights Holder

IMMVIRA CO., LIMITED

99
Address
Silver Star Hi-tech Industrial Park
1301 Guan-Guang Road, Bldg. 2, Fl. 10
Longhua Dist.,Shenzhen 518110
CN

Ownership History

IMMVIRA CO., LIMITED

Original Applicant
99
Longhua Dist.,Shenzhen CN

IMMVIRA CO., LIMITED

Owner at Publication
99
Longhua Dist.,Shenzhen CN

Legal Representation

Attorney
Angel Roman Campos

USPTO Deadlines

Next Deadline
35 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
September 03, 2025
Extension Available
Until September 03, 2025

Application History

12 events
Date Code Type Description Documents
Feb 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 15, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 14, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 14, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 3, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 9, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 9, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 19, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 4, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 4, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 7, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 19, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Antiseptics; Biological preparations for the treatment of cancer; Human vaccine preparations; Immunostimulants; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Oral vaccine preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations, namely, antivirals; Vaccine preparations; Vaccines; Viral vaccines

Classification

International Classes
005